Oxxynova GmbH - Company Review
Oxxynova GmbH - Company ReviewSummary
Oxxynova GmbH (Oxxynova), a subsidiary of ARQUES Industries AG is a chemical company that manufactures and markets liquid dimethyl terephthalate and its derivatives. The company’s liquid dimethyl terephthalate is used in manufacturing of polyester fibres, technical resins and films. It produces various DMT-related xylol derivatives. Oxxynova also provides development and disposal of chemical by-products. The company provides recycling of side-streams and logistic services. Its products are used in capacitors, cable insulation, polyester resins, photovoltaic applications, LCD screens, seat covers, tarpaulins, lorry tarpaulins, and others. The company caters to telecommunications, automotive, consumer goods, electrical and food packaging industries. Oxxynova is headquartered in Steyerberg, Germany.
This comprehensive company report of Oxxynova GmbH provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.